AlzeCure Presents New Data Regarding the TrkA-NAM Pain Project at IASP ...
AlzeCure Presents New Data Regarding the TrkA-NAM Pain Project at IASP ...
Source: pr-inside.com
Stay updated with breaking news from Selective Negative Allosteric Modulator. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AlzeCure Presents New Data Regarding the TrkA-NAM Pain Project at IASP ...
AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops candidate drugs for CNS diseases, focusing on Alzheimer's disease and pain, today announced that an abstract on its preclinical project TrkA-NAM against osteoarthritis pain and other severe pain conditions has been accepted for presen...